Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Sensorion
  6. News
  7. Most relevant
    ALSEN   FR0012596468

SENSORION

(ALSEN)
  Report
Real-time Euronext Paris  -  11:35:21 2023-01-26 am EST
0.3750 EUR   -0.66%
01/03Sensorion Announces First Patient Enrolled in Phase 2a Proof of Concept Clinical Trial of SENS-401 in Cisplatin-Induced Ototoxicity
AQ
01/03Sensorion : Inside Information / Other news releases
PU
01/03Sensorion Recruits First Patient In Mid-stage Study Of Hearing Loss Drug
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about SENSORION
01/03Sensorion Announces First Patient Enrolled in Phase 2a Proof of Concept Clinical Trial ..
AQ
01/03Sensorion : Inside Information / Other news releases
PU
01/03Sensorion Recruits First Patient In Mid-stage Study Of Hearing Loss Drug
MT
01/03Sensorion SA Announces First Patient Enrolled in Phase 2a Proof of Concept Clinical Tri..
CI
2022Sensorion Wins US FDA's Orphan Drug Tag for Hearing Loss Gene Therapy
MT
2022Sensorion's Gene Therapy for Hearing Loss Wins Rare Pediatric Disease Tag in US
MT
2022Sensorion Announces US FDA Grants Rare Pediatric Disease Designation to Otof-Gt for the..
CI
2022Sensorion Wins Regulatory Nod to Launch Mid-Stage Study of Cisplatin-Induced Hearing Lo..
MT
2022Sensorion SA Announces Approval to Initiate amended Phase 2a Proof of Concept Clinical ..
CI
2022Sensorion SA Reports Earnings Results for the Half Year Ended June 30, 2022
CI
2022Sensorion Enrolls First Patient in SENS-401 Clinical Trial
MT
2022Sensorion Announces First Patient Enrolled in Proof-of-Concept Clinical Trial of SENS-4..
CI
2022Sensorion Receives Positive Opinion in Europe on Orphan Drug Designation for Hearing Lo..
MT
2022Sensorion Granted Australian Approval for Phase 2a Trial of SENS-401 in Patients Schedu..
MT
2022Sensorion Announces Approval in Australia to Initiate Proof of Concept Clinical Trial o..
CI
2022Sensorion Wins French Regulatory Nod to Conduct Mid-stage Study of Hearing Preservation..
MT
2022Sensorion Announces Approval in France to Initiate Proof of Concept Clinical Trial of S..
CI
2022Sensorion SA Reports Earnings Results for the Full Year Ended December 31, 2021
CI
2022Sensorion : Inside Information / Other news releases
PU
2022Sensorion SA Provides Update on SENS-401
CI
2022Sensorion : Inside Information / Other news releases
PU
2022Sensorion's Hearing Loss Therapy Fails in Mid-Stage Study
MT
2022Sensorion SA Updates on SENS-401 Phase 2 Trial in Sudden Sensorineural Hearing Loss
CI
2022Sensorion Appoints Aniz Girach as Independent Board Member Replacing Jean-François Mori..
CI
2021Sensorion SA Announces Executive Changes
CI
2021Sensorion Surpasses Enrollment Target for SENS-401 in SSNHL, Results Available in Janua..
CI
2021Global markets live: Boeing, Walgreens, Dufry, M&S, Novartis...
MS
2021Global markets live: Intel, Apple, Rolls-Royce, Raytheon, MGM...
MS
2021Sensorion Sa Reports Earnings Results for the Half Year Ended June 30, 2021
CI
2021Sensorion Announces Regulators Approval for Sensorion’s Amendment to Phase 2 Audible-S ..
CI
2021Global markets live: Microsoft, Apple, The Boeing Company, AT&T, Act..
MS
2021Sensorion : Sonova to Collaborate on Research of Genetic Analysis to Diagnose ..
MT
2021Sensorion and Sonova Signs Strategic Research Collaboration
CI
2021Sensorion : Cochlear to Start Pilot Study of Hearing Preservation Drug
MT
2021Sensorion and Cochlear to Begin First Clinical Trial of SENS-401 for Hearing Preservati..
CI
2021Sensorion Appoints Otmane Boussif as Chief Technical Officer, Effective August 1, 2021
CI
2021Sensorion Appoints Nora Yang as Chief Scientific Officer
CI
2021Vertigo Pipeline : Emerging Therapies and Key pharma players involved by DelveInsight | Au..
AQ
2021Sensorion : Publishes Results of Extraordinary General Meeting Resolutions
BU
2021Sensorion : Reports Full-Year 2020 Financial Results and Provides Business Highlights
BU
2021Sensorion Sa Reports Earnings Results for the Full Year Ended December 31, 2020
CI
2021Sensorion : to Present at Two Conferences on March 16th 2021
BU
2021Sensorion : Presents New Preclinical Data on SENS-401 at ARO 2021
BU
2021Sensorion Presents New Preclinical Data on SENS-401 at ARO 2021
CI
2021Sensorion : Announces That an Extraordinary General Meeting Will Be Held Behind Closed Doo..
BU
2021Sensorion : A Chardan Top Pick for 2021
BU
2021Sensorion : Adds New Gene Therapy Target to Development Portfolio to Address H..
MT
2021Sensorion Announces Third Gene Therapy Collaboration with Institut Pasteur Targeting Im..
CI
2021Sensorion : announces third gene therapy collaboration with Institut Pasteur targeting imp..
PU
2021Sensorion : Letter to Shareholders - 2021.
PU
2021Sensorion : announces preclinical data demonstrating SENS-401's potential to preserve resi..
PU
2021Sensorion : Half-year report on the Sensorion liquidity contract with Kepler Cheuvreux.
PU
2021Sensorion : Letter to Shareholders - 2021. Read
PU
2021Sensorion : Corporate presentation
PU
2021Sensorion : Says SENS-401 Product Reduces Loss of Residual Hearing; Shares Ris..
MT
2021Sensorion : announces preclinical data demonstrating SENS-401's potential to preserve resi..
PU
2021Sensorion : Announces Preclinical Data Demonstrating SENS-401's Potential to Preserve Resi..
BU
2021Sensorion Announces Preclinical Data Demonstrating SENS-401's Potential to Preserve Res..
CI
2021Sensorion : Half-year report on the Sensorion liquidity contract with Kepler Cheuvreux. Re..
PU
2021Sensorion : Half-year report on the Sensorion liquidity contract with Kepler Cheuvreux
BU
2021Sensorion : Corporate presentation
PU
2021Sensorion : announces initiation of coverage by investment banks Jefferies and Kempen with..
PU
2021Sensorion : Announces Initiation of Coverage by Investment Banks Jefferies and Kempen With..
BU
2021Sensorion : provides an update on plans and progress in the development of SENS-401 for th..
PU
2021Sensorion : Provides an Update on Plans and Progress in the Development of SENS-401 for th..
BU
2021Sensorion Provides an Update on Plans and Progress in the Development of SENS-401 for t..
CI
2020Sonova : Takes 4% Stake In Sensorion For $6.1 Million
MT
2020Sensorion : Sonova invests Ç5 million in Sensorion as the companies plan a collaboration i..
PU
2020Sensorion : Sonova Invests Ç5 Million in Sensorion as the Companies Plan a Collaboration i..
BU
2020Sensorion SA announced that it expects to receive €4.999999 million in funding fro..
CI
2020Sensorion : Hosting Key Opinion Leader Call with Dr. John Greinwald on Genetic Hearing Los..
BU
2020Sensorion : Balance of the liquidity contract to June 30, 2020. Read
PU
2020Sensorion : Corporate presentation
PU
2020Sensorion : announces attendance and a presentation at upcoming conferences. Read
PU
2020Sensorion : Announces Attendance and a Presentation at Upcoming Conferences
BU
1  2  3  4  5Next
Upcoming event on SENSORION